Current and historical daily PE Ratio for OKYO Pharma Ltd (
LSE:OKYO
) from 2018 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. OKYO Pharma stock (LSE:OKYO) PE ratio as of Jun 08 2024 is 0.
More Details
OKYO Pharma Ltd (LSE:OKYO) PE Ratio (TTM) Chart
OKYO Pharma Ltd (LSE:OKYO) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 930
- 1
- 2
- 3
- 4
- 5
- 6
- 11
| OKYO Pharma PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-08 | At Loss | 2023-03-03 | At Loss |
| 2023-05-10 | At Loss | 2023-03-02 | At Loss |
| 2023-05-09 | At Loss | 2023-03-01 | At Loss |
| 2023-05-08 | At Loss | 2023-02-28 | At Loss |
| 2023-05-05 | At Loss | 2023-02-27 | At Loss |
| 2023-05-04 | At Loss | 2023-02-24 | At Loss |
| 2023-05-03 | At Loss | 2023-02-23 | At Loss |
| 2023-05-02 | At Loss | 2023-02-22 | At Loss |
| 2023-04-28 | At Loss | 2023-02-21 | At Loss |
| 2023-04-27 | At Loss | 2023-02-20 | At Loss |
| 2023-04-26 | At Loss | 2023-02-17 | At Loss |
| 2023-04-25 | At Loss | 2023-02-16 | At Loss |
| 2023-04-21 | At Loss | 2023-02-15 | At Loss |
| 2023-04-20 | At Loss | 2023-02-14 | At Loss |
| 2023-04-19 | At Loss | 2023-02-13 | At Loss |
| 2023-04-18 | At Loss | 2023-02-10 | At Loss |
| 2023-04-17 | At Loss | 2023-02-09 | At Loss |
| 2023-04-14 | At Loss | 2023-02-08 | At Loss |
| 2023-04-13 | At Loss | 2023-02-07 | At Loss |
| 2023-04-12 | At Loss | 2023-02-06 | At Loss |
| 2023-04-11 | At Loss | 2023-02-03 | At Loss |
| 2023-04-06 | At Loss | 2023-02-02 | At Loss |
| 2023-04-05 | At Loss | 2023-02-01 | At Loss |
| 2023-04-04 | At Loss | 2023-01-30 | At Loss |
| 2023-04-03 | At Loss | 2023-01-27 | At Loss |
| 2023-03-31 | At Loss | 2023-01-26 | At Loss |
| 2023-03-30 | At Loss | 2023-01-25 | At Loss |
| 2023-03-29 | At Loss | 2023-01-24 | At Loss |
| 2023-03-28 | At Loss | 2023-01-23 | At Loss |
| 2023-03-27 | At Loss | 2023-01-20 | At Loss |
| 2023-03-24 | At Loss | 2023-01-19 | At Loss |
| 2023-03-23 | At Loss | 2023-01-18 | At Loss |
| 2023-03-22 | At Loss | 2023-01-17 | At Loss |
| 2023-03-21 | At Loss | 2023-01-16 | At Loss |
| 2023-03-20 | At Loss | 2023-01-13 | At Loss |
| 2023-03-17 | At Loss | 2023-01-12 | At Loss |
| 2023-03-16 | At Loss | 2023-01-11 | At Loss |
| 2023-03-15 | At Loss | 2023-01-10 | At Loss |
| 2023-03-14 | At Loss | 2023-01-09 | At Loss |
| 2023-03-13 | At Loss | 2023-01-06 | At Loss |
| 2023-03-10 | At Loss | 2023-01-05 | At Loss |
| 2023-03-09 | At Loss | 2023-01-04 | At Loss |
| 2023-03-08 | At Loss | 2023-01-03 | At Loss |
| 2023-03-07 | At Loss | 2022-12-30 | At Loss |
| 2023-03-06 | At Loss | 2022-12-29 | At Loss |
OKYO Pharma Ltd (LSE:OKYO) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
OKYO Pharma Ltd
NAICS : 213114
ISIN : GG00BD3FV870
Description
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers